Index by author

01 April 2008; volume 31, issue 4

A

  1. Ambrosino, N.

    1. Ambrosino, N., and G. Vagheggini. "Noninvasive positive pressure ventilation in the acute care setting: where are we?." European Respiratory Journal 31.4 (2008): 874-886. Web. 01 Mar. 2021.

  2. Amis, T. C.

    1. Hallani, M., J. R. Wheatley, and T. C. Amis. "Initiating oral breathing in response to nasal loading: asthmatics versus healthy subjects." European Respiratory Journal 31.4 (2008): 800-806. Web. 01 Mar. 2021.

  3. Anderson, S. D.

    1. Daviskas, E. et al "Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis." European Respiratory Journal 31.4 (2008): 765-772. Web. 01 Mar. 2021.

  4. Anderson, W.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  5. Annemans, L.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  6. Argyropoulou, P.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  7. Aubert, A.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

B

  1. Beermann, W.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  2. Beffa, P.

    1. Beffa, P. et al "Indeterminate test results of T-SPOTTM.TB performed under routine field conditions." European Respiratory Journal 31.4 (2008): 842-846. Web. 01 Mar. 2021.

  3. Besozzi, G.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  4. Blondeau, K.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  5. Bogaard, H. J.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  6. Boonstra, A.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  7. Bouros, D.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  8. Brambilla, C.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  9. Brambilla, E.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  10. Brändli, O.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  11. Braun, J.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  12. Brichon, P. Y.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  13. Brusselle, G.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  14. Brzoza, Z.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

  15. Buhl, R.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  16. Burkhart, D.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  17. Bush, A.

    1. Bush, A.. "Regulating spoons." European Respiratory Journal 31.4 (2008): 699-700. Web. 01 Mar. 2021.

C

  1. Calvert, L. D.

    1. Calvert, L. D. et al "The plasma ammonia response to cycle exercise in COPD." European Respiratory Journal 31.4 (2008): 751-758. Web. 01 Mar. 2021.

  2. Casadio, C.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  3. Cassino, C.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  4. Celli, B.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  5. Centis, R.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  6. Chang, J.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  7. Chang, K. C.

    1. Chang, K. C., and C. C. Leung. "Meta-analysis may not be practicable for guiding antibiotic therapy." European Respiratory Journal 31.4 (2008): 906-907. Web. 01 Mar. 2021.

  8. Cirillo, D. M.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  9. Codecasa, L. R.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  10. Coxson, H. O.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  11. Crim, C.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  12. Czecior, E.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

D

  1. Davies, D. E.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

  2. Daviskas, E.

    1. Daviskas, E. et al "Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis." European Respiratory Journal 31.4 (2008): 765-772. Web. 01 Mar. 2021.

  3. Dawber, F.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  4. De Baets, F.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  5. De Boeck, K.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  6. De Bolle, L.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  7. Decramer, M.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  8. Della Pona, C.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  9. Del Rey, J.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  10. Diab, S.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  11. Díaz, G.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  12. Dimopoulos, G.

    1. Siempos, I. I., G. Dimopoulos, and M. E. Falagas. " From the authors ." European Respiratory Journal 31.4 (2008): 907-908. Web. 01 Mar. 2021.

  13. Djukanović, R.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

  14. Domanski, U.

    1. Nilius, G. et al "Impact of a controlled heated breathing tube humidifier on sleep quality during CPAP therapy in a cool sleeping environment." European Respiratory Journal 31.4 (2008): 830-836. Web. 01 Mar. 2021.

  15. Dudbridge, F.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  16. Dupont, L. J.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

E

  1. Eapen, G. A.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  2. Eberl, S.

    1. Daviskas, E. et al "Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis." European Respiratory Journal 31.4 (2008): 765-772. Web. 01 Mar. 2021.

  3. Edwards, L.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  4. Efthimiadis, G. K.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  5. Eikenboom, J. C. J.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  6. Eitel, J.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  7. Escobar, C.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

F

  1. Falagas, M. E.

    1. Siempos, I. I., G. Dimopoulos, and M. E. Falagas. " From the authors ." European Respiratory Journal 31.4 (2008): 907-908. Web. 01 Mar. 2021.

  2. Fossella, F.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  3. Franke, K-J.

    1. Nilius, G. et al "Impact of a controlled heated breathing tube humidifier on sleep quality during CPAP therapy in a cool sleeping environment." European Respiratory Journal 31.4 (2008): 830-836. Web. 01 Mar. 2021.

G

  1. García-Rull, S.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  2. Gelfand, E. W.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  3. Giannakoulas, G.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  4. Girardi, E.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  5. Goldsmith, K.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  6. Gomberg-Maitland, M.

    1. Gomberg-Maitland, M., and H. Olschewski. "Prostacyclin therapies for the treatment of pulmonary arterial hypertension." European Respiratory Journal 31.4 (2008): 891-901. Web. 01 Mar. 2021.

  7. Gosker, H. R.

    1. Gosker, H. R., and A. M. W. J. Schols. "Fatigued muscles in COPD but no finishing line in sight." European Respiratory Journal 31.4 (2008): 693-694. Web. 01 Mar. 2021.

  8. Grasemann, C.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  9. Grasemann, H.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  10. Greenhaff, P. L.

    1. Calvert, L. D. et al "The plasma ammonia response to cycle exercise in COPD." European Respiratory Journal 31.4 (2008): 751-758. Web. 01 Mar. 2021.

  11. Grimfed, A.

    1. Laoudi, Y. et al "Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?." European Respiratory Journal 31.4 (2008): 908-909. Web. 01 Mar. 2021.

H

  1. Hagan, G.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  2. Hallani, M.

    1. Hallani, M., J. R. Wheatley, and T. C. Amis. "Initiating oral breathing in response to nasal loading: asthmatics versus healthy subjects." European Respiratory Journal 31.4 (2008): 800-806. Web. 01 Mar. 2021.

  3. Hamada, K.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

  4. Heinz, A.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  5. Held, L.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  6. Hippenstiel, S.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  7. Hocke, A. C.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  8. Holverda, S.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

I

  1. Ito, T.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

J

  1. Jaakkola, M. S.

    1. Sripaiboonkij, P., W. Phanprasit, and M. S. Jaakkola. "Respiratory effects of occupational exposures in a milk powder factory." European Respiratory Journal 31.4 (2008): 807-814. Web. 01 Mar. 2021.

  2. Janssens, J-P.

    1. Beffa, P. et al "Indeterminate test results of T-SPOTTM.TB performed under routine field conditions." European Respiratory Journal 31.4 (2008): 842-846. Web. 01 Mar. 2021.

  3. Jimenez, C. A.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  4. Jiménez, D.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  5. Just, J.

    1. Laoudi, Y. et al "Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?." European Respiratory Journal 31.4 (2008): 908-909. Web. 01 Mar. 2021.

K

  1. Kai, Y.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

  2. Karamitsos, T. D.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  3. Karvounis, H. I.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  4. Kasperska-Zajac, A.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

  5. Kennedy, M. P.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  6. Kesten, S.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  7. Kimura, H.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

  8. Kliiman, K.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  9. Knobil, K.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  10. Kontakiotis, T.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  11. Kuster, D.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  12. Kuster, S. P.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

L

  1. Lange, C.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  2. Lantuejoul, S.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  3. Laoudi, Y.

    1. Laoudi, Y. et al "Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?." European Respiratory Journal 31.4 (2008): 908-909. Web. 01 Mar. 2021.

  4. Lau, L. C.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

  5. Lebecque, P.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  6. Leclercq-Foucart, J.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  7. Leung, C. C.

    1. Chang, K. C., and C. C. Leung. "Meta-analysis may not be practicable for guiding antibiotic therapy." European Respiratory Journal 31.4 (2008): 906-907. Web. 01 Mar. 2021.

  8. Ling, Y.

    1. Ling, Y., W. Saleem, and C. D. Shee. "Concomitant use of β-blockers and β2-agonists." European Respiratory Journal 31.4 (2008): 905-906. Web. 01 Mar. 2021.

  9. Liu, D.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  10. Lomas, D. A.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  11. Long, L.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

M

  1. MacNee, W.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  2. Malfroot, A.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  3. Mannino, D. M.

    1. Soriano, J. B., and D. M. Mannino. "Reversing concepts on COPD irreversibility." European Respiratory Journal 31.4 (2008): 695-696. Web. 01 Mar. 2021.

  4. Maqami, L.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  5. Marcus, J. T.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  6. Martí, D.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  7. Massera, F.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  8. Mehuys, E.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  9. Mertens, V.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  10. Migliori, G. B.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  11. Molina, J.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  12. Morgan, M. D.

    1. Calvert, L. D. et al "The plasma ammonia response to cycle exercise in COPD." European Respiratory Journal 31.4 (2008): 751-758. Web. 01 Mar. 2021.

  13. Morice, R. C.

    1. Kennedy, M. P. et al "Optimisation of bronchial brachytherapy catheter placement with a modified airway stent." European Respiratory Journal 31.4 (2008): 902-903. Web. 01 Mar. 2021.

  14. Moro-Sibilot, D.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  15. Morrell, N. W.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  16. Moulai, N.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

N

  1. N'Guessan, P. D.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  2. Nakajima, Y.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

  3. Namyslowski, G.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

  4. Nilius, G.

    1. Nilius, G. et al "Impact of a controlled heated breathing tube humidifier on sleep quality during CPAP therapy in a cool sleeping environment." European Respiratory Journal 31.4 (2008): 830-836. Web. 01 Mar. 2021.

  5. Nomi, T.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

O

  1. Olschewski, H.

    1. Gomberg-Maitland, M., and H. Olschewski. "Prostacyclin therapies for the treatment of pulmonary arterial hypertension." European Respiratory Journal 31.4 (2008): 891-901. Web. 01 Mar. 2021.

  2. Opitz, B.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

P

  1. Paolini, J-B.

    1. Laoudi, Y. et al "Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?." European Respiratory Journal 31.4 (2008): 908-909. Web. 01 Mar. 2021.

  2. Papadopoulos, C. E.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  3. Papalia, E.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  4. Parharidis, G. E.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  5. Pepke-Zaba, J.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  6. Phanprasit, W.

    1. Sripaiboonkij, P., W. Phanprasit, and M. S. Jaakkola. "Respiratory effects of occupational exposures in a milk powder factory." European Respiratory Journal 31.4 (2008): 807-814. Web. 01 Mar. 2021.

  7. Pitsiou, G.

    1. Papadopoulos, C. E. et al "Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study." European Respiratory Journal 31.4 (2008): 701-706. Web. 01 Mar. 2021.

  8. Polok, A.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

  9. Postmus, P. E.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  10. Proesmans, M.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

R

  1. Ratjen, F.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  2. Remon, J. P.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  3. Rena, O.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  4. Reuter, S.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  5. Reutershahn, E.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  6. Rietema, H.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  7. Robustellini, M.

    1. Rena, O. et al "Surgical pleurodesis for Vanderschueren's stage III primary spontaneous pneumothorax." European Respiratory Journal 31.4 (2008): 837-841. Web. 01 Mar. 2021.

  8. Rochat, M. K.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  9. Rogala, B.

    1. Kasperska-Zajac, A. et al "Elevated levels of exhaled nitric oxide in recurrent tonsillitis." European Respiratory Journal 31.4 (2008): 909-910. Web. 01 Mar. 2021.

  10. Ruhle, K-H.

    1. Nilius, G. et al "Impact of a controlled heated breathing tube humidifier on sleep quality during CPAP therapy in a cool sleeping environment." European Respiratory Journal 31.4 (2008): 830-836. Web. 01 Mar. 2021.

  11. Rytila, P.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

S

  1. Saleem, W.

    1. Ling, Y., W. Saleem, and C. D. Shee. "Concomitant use of β-blockers and β2-agonists." European Respiratory Journal 31.4 (2008): 905-906. Web. 01 Mar. 2021.

  2. Schelstraete, P.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  3. Schindler, C.

    1. Kuster, S. P. et al "Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years." European Respiratory Journal 31.4 (2008): 860-868. Web. 01 Mar. 2021.

  4. Schmeck, B.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  5. Schnabel, D.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  6. Schols, A. M. W. J.

    1. Gosker, H. R., and A. M. W. J. Schols. "Fatigued muscles in COPD but no finishing line in sight." European Respiratory Journal 31.4 (2008): 693-694. Web. 01 Mar. 2021.

  7. Seumois, G.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

  8. Shee, C. D.

    1. Ling, Y., W. Saleem, and C. D. Shee. "Concomitant use of β-blockers and β2-agonists." European Respiratory Journal 31.4 (2008): 905-906. Web. 01 Mar. 2021.

  9. Sho, M.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

  10. Siempos, I. I.

    1. Siempos, I. I., G. Dimopoulos, and M. E. Falagas. " From the authors ." European Respiratory Journal 31.4 (2008): 907-908. Web. 01 Mar. 2021.

  11. Sieren, M.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  12. Sifrim, D.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  13. Silverman, E. K.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  14. Singh, S. J.

    1. Calvert, L. D. et al "The plasma ammonia response to cycle exercise in COPD." European Respiratory Journal 31.4 (2008): 751-758. Web. 01 Mar. 2021.

  15. Slevogt, H.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  16. Smit, H. J.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  17. Soriano, J. B.

    1. Soriano, J. B., and D. M. Mannino. "Reversing concepts on COPD irreversibility." European Respiratory Journal 31.4 (2008): 695-696. Web. 01 Mar. 2021.

  18. Spanevello, A.

    1. Migliori, G. B. et al "Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?." European Respiratory Journal 31.4 (2008): 904-905. Web. 01 Mar. 2021.

  19. Sripaiboonkij, P.

    1. Sripaiboonkij, P., W. Phanprasit, and M. S. Jaakkola. "Respiratory effects of occupational exposures in a milk powder factory." European Respiratory Journal 31.4 (2008): 807-814. Web. 01 Mar. 2021.

  20. Stassen, M.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  21. Steiner, M. C.

    1. Calvert, L. D. et al "The plasma ammonia response to cycle exercise in COPD." European Respiratory Journal 31.4 (2008): 751-758. Web. 01 Mar. 2021.

  22. Sueiro, A.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  23. Suntharalingam, J.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  24. Suttorp, N.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  25. Suzaki, Y.

    1. Suzaki, Y. et al "A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation." European Respiratory Journal 31.4 (2008): 783-789. Web. 01 Mar. 2021.

T

  1. Tal-Singer, R.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  2. Tashkin, D. P.

    1. Tashkin, D. P. et al "Bronchodilator responsiveness in patients with COPD." European Respiratory Journal 31.4 (2008): 742-750. Web. 01 Mar. 2021.

  3. Taube, C.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  4. Timsit, J. F.

    1. Moro-Sibilot, D. et al "Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis." European Respiratory Journal 31.4 (2008): 854-859. Web. 01 Mar. 2021.

  5. Toshner, M. R.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  6. Treacy, C. M.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

U

  1. Uddin, M.

    1. Uddin, M. et al "Enhancement of neutrophil function by the bronchial epithelium stimulated by epidermal growth factor." European Respiratory Journal 31.4 (2008): 714-724. Web. 01 Mar. 2021.

V

  1. Vagheggini, G.

    1. Ambrosino, N., and G. Vagheggini. "Noninvasive positive pressure ventilation in the acute care setting: where are we?." European Respiratory Journal 31.4 (2008): 874-886. Web. 01 Mar. 2021.

  2. Vanaudenaerde, B. A.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  3. Van Bortel, L.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  4. Van daele, S.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  5. Vaneechoutte, M.

    1. Schelstraete, P. et al "Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 822-829. Web. 01 Mar. 2021.

  6. van Marion, V.

    1. Suntharalingam, J. et al "Fibrinogen Aα Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension." European Respiratory Journal 31.4 (2008): 736-741. Web. 01 Mar. 2021.

  7. Van Raemdonck, D. E.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  8. Van Tongelen, I.

    1. Mehuys, E. et al "Effectiveness of pharmacist intervention for asthma control improvement." European Respiratory Journal 31.4 (2008): 790-799. Web. 01 Mar. 2021.

  9. Vardarowa, K.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  10. Verleden, G. M.

    1. Blondeau, K. et al "Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection." European Respiratory Journal 31.4 (2008): 707-713. Web. 01 Mar. 2021.

  11. Vestbo, J.

    1. Vestbo, J. et al "Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)." European Respiratory Journal 31.4 (2008): 869-873. Web. 01 Mar. 2021.

  12. Vester, U.

    1. Grasemann, C. et al "Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients." European Respiratory Journal 31.4 (2008): 815-821. Web. 01 Mar. 2021.

  13. Vidal, R.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

  14. Vonk-Noordegraaf, A.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

W

  1. Wagner, P. D.

    1. Wagner, P. D.. "The biology of oxygen." European Respiratory Journal 31.4 (2008): 887-890. Web. 01 Mar. 2021.

  2. Weimann, A.

    1. Slevogt, H. et al "Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms." European Respiratory Journal 31.4 (2008): 725-735. Web. 01 Mar. 2021.

  3. Weissmann, N.

    1. Weissmann, N.. "Hypoxia-driven mechanisms in lung biology and disease: a new review series of the ERS Lung Science Conference." European Respiratory Journal 31.4 (2008): 697-698. Web. 01 Mar. 2021.

  4. Westerhof, N.

    1. Rietema, H. et al "Sildenafil treatment in COPD does not affect stroke volume or exercise capacity." European Respiratory Journal 31.4 (2008): 759-764. Web. 01 Mar. 2021.

  5. Wheatley, J. R.

    1. Hallani, M., J. R. Wheatley, and T. C. Amis. "Initiating oral breathing in response to nasal loading: asthmatics versus healthy subjects." European Respiratory Journal 31.4 (2008): 800-806. Web. 01 Mar. 2021.

  6. Wiewrodt, R.

    1. Reuter, S. et al "Mast cell-derived tumour necrosis factor is essential for allergic airway disease." European Respiratory Journal 31.4 (2008): 773-782. Web. 01 Mar. 2021.

  7. Wrighton-Smith, P.

    1. Beffa, P. et al "Indeterminate test results of T-SPOTTM.TB performed under routine field conditions." European Respiratory Journal 31.4 (2008): 842-846. Web. 01 Mar. 2021.

Y

  1. Young, I. H.

    1. Daviskas, E. et al "Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis." European Respiratory Journal 31.4 (2008): 765-772. Web. 01 Mar. 2021.

  2. Yusen, R. D.

    1. Jiménez, D. et al "Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism." European Respiratory Journal 31.4 (2008): 847-853. Web. 01 Mar. 2021.

Z

  1. Zellweger, A.

    1. Beffa, P. et al "Indeterminate test results of T-SPOTTM.TB performed under routine field conditions." European Respiratory Journal 31.4 (2008): 842-846. Web. 01 Mar. 2021.

  2. Zellweger, J-P.

    1. Beffa, P. et al "Indeterminate test results of T-SPOTTM.TB performed under routine field conditions." European Respiratory Journal 31.4 (2008): 842-846. Web. 01 Mar. 2021.
Back to top
European Respiratory Journal: 31 (4)

Search Within This Issue

Jump to

Manage Table of content Alerts